FindTrial
Sign In

To study the effect of Rasnadi Churna and Chaturbija Churna in the management of knee joint pain (Osteoarthritis).

A clinico-comparative study of Rasnadi Churna and Chaturbija Churna in the management of Janusandhigata Vata

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/05/025174
Enrollment
30
Registered
2020-05-14
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M179- Osteoarthritis of knee, unspecified

Interventions

Intervention1: Internal administration of Rasnadi Churna and Chaturbija Churna: There are two groups in the study. One group of 15 patients is given internal administration of Rasnadi Churna 6 gm divi

Sponsors

Government Akhandanand Ayurved Mahavidhyalaya Bhadra Ahmedabad
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Chronicity up to 5 years. Traumatic arthritis. Patients having sign and symptoms of Janusandhigata Vata with fulfilling the diagnostic criteria.

Exclusion criteria

Exclusion criteria: Age below 30 years and above 70 years. Patient suffering from Vatarkta, Amavata, systemic lupus erythmetus(SLE), Psoriatic arthritis,infective arthritis and other systemic serious disorders will be excluded.

Design outcomes

Primary

MeasureTime frame
Result will be assessed on the basis of relief signs and symptoms of Janusandhigata vataTimepoint: 4 weeks—

Secondary

MeasureTime frame
By comparing the effect of both drugs in the management of Janusandhigata VataTimepoint: 4 weeks—

Countries

India

Contacts

Public ContactDr Surendra A Soni

Gujarat Ayurved University, Jamnagar

surendraasoni@gmail.com9808441150

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026